Cost-effectiveness of stereotactic 11-gauge directional vacuum-assisted breast biopsy.

OBJECTIVE The purpose of our study was to determine the frequency with which stereotactic 11-gauge directional vacuum-assisted breast biopsy obviated a surgical procedure and to calculate cost savings attributable to that biopsy method. MATERIALS AND METHODS We retrospectively reviewed 200 consecutive solitary nonpalpable lesions on which stereotactic 11-gauge directional vacuum-assisted breast biopsy was performed. Cost savings were calculated using Medicare reimbursements. Mammograms, histologic findings, and medical records were reviewed. RESULTS Stereotactic 11-gauge directional vacuum-assisted biopsy obviated a surgical procedure in 151 (76%) of 200 lesions, including 112 (73%) of 154 calcific lesions and 39 (85%) of 46 masses. Reasons for not obviating a surgical procedure in 49 lesions (25%) included recommendation for surgical biopsy in 35 lesions (18%), small carcinomas treated by excision in 10 lesions (5%), and histologic underestimation in four lesions (2%). Stereotactic 11-gauge directional vacuum-assisted biopsy decreased the cost of diagnosis by S264 per case, a 20% ($264/$1289) decrease in the cost of diagnosis compared with surgical biopsy. Of 200 lesions that had stereotactic 11-gauge directional vacuum-assisted biopsy, 106 (53%) would not have been amenable to 14-gauge automated core biopsy because of their small size, their superficial location, or inadequate breast thickness. CONCLUSION Stereotactic 11-gauge directional vacuum-assisted breast biopsy obviated a surgical procedure in 76% of lesions, yielding a 20% decrease in cost of diagnosis compared with surgical biopsy. Although savings per case are modest, 11-gauge directional vacuum-assisted biopsy expands the spectrum of lesions amenable to stereotactic biopsy, increasing cost savings in the population.

[1]  J. Meyer,et al.  Large-core needle biopsy of nonpalpable breast lesions. , 1999, JAMA.

[2]  C. Lee,et al.  Canceled stereotactic core-needle biopsy of the breast: analysis of 89 cases. , 1997, Radiology.

[3]  L. Liberman,et al.  Calcification retrieval at stereotactic, 11-gauge, directional, vacuum-assisted breast biopsy. , 1998, Radiology.

[4]  L. Liberman,et al.  Impact of stereotaxic core breast biopsy on cost of diagnosis. , 1995, Radiology.

[5]  F. Burbank,et al.  Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization. , 1997, Radiology.

[6]  D. Kopans.  Caution on core. , 1994, Radiology.

[7]  M. Lechner,et al.  Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. , 1993, Radiology.

[8]  L. Fajardo,et al.  Estimating the cost-effectiveness of stereotaxic biopsy for nonpalpable breast abnormalities: a decision analysis model. , 1996, Academic radiology.

[9]  Joanne F. Cousins,et al.  Interventional breast procedures. , 1998, Current problems in diagnostic radiology.

[10]  L. Fajardo.  Cost-effectiveness of stereotaxic breast core needle biopsy. , 1996, Academic radiology.

[11]  L. Liberman,et al.  Stereotactic core biopsy of calcifications highly suggestive of malignancy. , 1997, Radiology.

[12]  C. J. Rosenquist,et al.  Needle core biopsy guided with mammography: a study of cost-effectiveness. , 1994, Radiology.

[13]  L. Liberman,et al.  US-guided core breast biopsy: use and cost-effectiveness. , 1998, Radiology.

[14]  H. E. Reynolds,et al.  Biopsy of breast microcalcifications using an 11-gauge directional vacuum-assisted device. , 1998, AJR. American journal of roentgenology.

[15]  S. Parker,et al.  A practical approach to minimally invasive breast biopsy. , 1996, Radiology.

[16]  I Tocino,et al.  Cost-effectiveness of stereotactic core needle biopsy: analysis by means of mammographic findings. , 1997, Radiology.

[17]  L. Liberman,et al.  Nondiagnostic stereotaxic core breast biopsy: results of rebiopsy. , 1996, Radiology.

[18]  V. Jackson,et al.  Stereotactic biopsy of ductal carcinoma in situ of the breast using an 11-gauge vacuum-assisted device: persistent underestimation of disease. , 1999, AJR. American journal of roentgenology.

[19]  R. J. Jackman,et al.  Needle-localized breast biopsy: why do we fail? , 1997, Radiology.

[20]  L. Liberman,et al.  Clip placement after stereotactic vacuum-assisted breast biopsy. , 1997, Radiology.

[21]  C. Lee,et al.  Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. , 1999, AJR. American journal of roentgenology.

[22]  K. Hopper,et al.  Nonpalpable breast lesions: stereotactic automated large-core biopsies. , 1991, Radiology.

[23]  R. J. Jackman,et al.  Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. , 1999, Radiology.

[24]  J. Meyer,et al.  Stereotactic breast biopsy of clustered microcalcifications with a directional, vacuum-assisted device. , 1997, Radiology.

[25]  A. Stavros,et al.  US-guided automated large-core breast biopsy. , 1993, Radiology.

[26]  F. Burbank.  Mammographic findings after 14-gauge automated needle and 14-gauge directional, vacuum-assisted stereotactic breast biopsies. , 1997, Radiology.

[27]  I Tocino,et al.  Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate. , 1999, Radiology.

[28]  K. Hopper,et al.  Stereotactic breast biopsy with a biopsy gun. , 1990, Radiology.

[29]  M. Kaye,et al.  Mammographic findings after stereotaxic biopsy of the breast performed with large-core needles. , 1994, Radiology.